Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis

Clin Liver Dis. 2022 Nov;26(4):583-611. doi: 10.1016/j.cld.2022.06.003. Epub 2022 Sep 14.

Abstract

Primary biliary cholangitis (PBC) is an autoimmune liver disease with a female predisposition and selective destruction of intrahepatic small bile ducts leading to nonsuppurative destructive cholangitis. It is characterized by seropositivity of antimitochondrial antibodies or PBC-specific antinuclear antibodies, progressive cholestasis, and typical liver histologic manifestations. Destruction of the protective bicarbonate-rich umbrella is attributed to the decreased expression of membrane transporters in biliary epithelial cells (BECs), leading to the accumulation of hydrophobic bile acids and sensitizing BECs to apoptosis. A recent X-wide association study reveals a novel risk locus on the X chromosome, which reiterates the importance of Treg cells.

Keywords: Apoptosis; Bile acids; Biliary epithelial cell; Immune tolerance; Microbiome; Senescence; X chromosome.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Antinuclear
  • Bicarbonates / metabolism
  • Bile Acids and Salts / metabolism
  • Bile Ducts
  • Cholangitis*
  • Female
  • Humans
  • Liver Cirrhosis, Biliary* / metabolism
  • Membrane Transport Proteins / metabolism

Substances

  • Bicarbonates
  • Antibodies, Antinuclear
  • Bile Acids and Salts
  • Membrane Transport Proteins